Point72 Middle East Fze Dexcom Inc Call Options Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$75.49 - $124.16 $135,882 - $223,488
-1,800 Reduced 16.07%
9,400 $1.17 Million
Q3 2023

Nov 14, 2023
BUY
$86.06 - $137.93 $869,206 - $1.39 Million
10,100 Added 918.18%
11,200 $1.04 Million
Q2 2023

Aug 14, 2023
BUY
$112.47 - $130.98 $101,223 - $117,881
900 Added 450.0%
1,100 $141,000
Q1 2023

May 15, 2023
BUY
$104.0 - $122.92 $20,800 - $24,584
200 New
200 $23,000

Others Institutions Holding DXCM

# of Institutions
1,013
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email